Organogenesis Holdings Inc. Goodwill & Intangibles Disclosure
9. Goodwill and Intangible Assets
Goodwill was $28,772 as of December 31, 2025 and 2024. There was no impairment of goodwill recorded during the years ended December 31, 2025, 2024, or 2023.
Identifiable intangible assets consisted of the following as of December 31, 2025:
|
|
Original |
|
|
Accumulated |
|
|
Net Book |
|
|||
|
|
Cost |
|
|
Amortization |
|
|
Value |
|
|||
Developed technology |
|
$ |
32,620 |
|
|
$ |
(28,724 |
) |
|
|
3,896 |
|
Customer relationship |
|
|
10,690 |
|
|
|
(5,657 |
) |
|
|
5,033 |
|
Patent |
|
|
7,623 |
|
|
|
(7,623 |
) |
|
|
— |
|
Independent sales agency network |
|
|
4,500 |
|
|
|
(4,500 |
) |
|
|
— |
|
Trade names and trademarks |
|
|
2,080 |
|
|
|
(1,864 |
) |
|
|
216 |
|
Non-compete agreements |
|
|
1,010 |
|
|
|
(1,010 |
) |
|
|
— |
|
Total |
|
$ |
58,523 |
|
|
$ |
(49,378 |
) |
|
|
9,145 |
|
Identifiable intangible assets consisted of the following as of December 31, 2024:
|
|
Original |
|
|
Accumulated |
|
|
Net Book |
|
|||
|
|
Cost |
|
|
Amortization |
|
|
Value |
|
|||
Developed technology |
|
$ |
32,620 |
|
|
$ |
(26,708 |
) |
|
$ |
5,912 |
|
Customer relationship |
|
|
10,690 |
|
|
|
(4,588 |
) |
|
|
6,102 |
|
Patent |
|
|
7,623 |
|
|
|
(7,623 |
) |
|
|
— |
|
Independent sales agency network |
|
|
4,500 |
|
|
|
(4,500 |
) |
|
|
— |
|
Trade names and trademarks |
|
|
2,080 |
|
|
|
(1,733 |
) |
|
|
347 |
|
Non-compete agreements |
|
|
1,010 |
|
|
|
(903 |
) |
|
|
107 |
|
Total |
|
$ |
58,523 |
|
|
$ |
(46,055 |
) |
|
$ |
12,468 |
|
Amortization of intangible assets, calculated on a straight-line basis or using an accelerated method, which reflects the pattern in which the economic benefits of the intangible assets are consumed, was $3,323, $3,403 and $4,918 for the years ended December 31, 2025, 2024, and 2023, respectively. The weighted average remaining useful lives for developed technology,
customer relationships, trade names and trademarks are 2.7 years, 4.8 years, and 2.6 years, respectively, as of December 31, 2025. Estimated future annual amortization expense related to these intangible assets is as follows:
2026 |
|
$ |
3,043 |
|
2027 |
|
|
2,283 |
|
2028 |
|
|
1,968 |
|
2029 |
|
|
1,094 |
|
2030 |
|
|
757 |
|
Total |
|
$ |
9,145 |
|
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 26, 2026 | Showing above |
| 2024 | Feb 27, 2025 | |
| 2023 | Feb 29, 2024 | |
| 2022 | Mar 1, 2023 | |
| 2021 | Mar 1, 2022 | |
About Goodwill & Intangibles Disclosures
Goodwill and intangible asset disclosures reveal the premium paid in acquisitions and how management assesses whether that premium retains its value. Since goodwill is no longer amortized under US GAAP, the annual impairment test is the only mechanism that adjusts carrying values downward — making the assumptions behind that test critically important for investors.
Key signals: a history of goodwill impairments suggests management consistently overpays for acquisitions. Watch the gap between reporting unit fair value and carrying amount — when fair value exceeds carrying amount by less than 10-20%, a small decline in business performance could trigger a write-down. For finite-lived intangibles, examine useful life assumptions across customer relationships, technology, and trade names; aggressive estimates inflate near-term earnings. Compare total intangibles-to-total-assets ratios against peers to assess acquisition dependency. Rising goodwill as a percentage of equity can signal balance sheet fragility.